Galecto Prices Public Offering at $19.00 per Share

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Apr 01 2026

0mins

Source: Newsfilter

Galecto Inc. saw a significant price increase of 26.15% as it crossed above its 5-day SMA amid broader market declines.

The company has priced its underwritten public offering at $19.00 per share for approximately 14.47 million shares, expecting to raise about $275 million to support its R&D and operations. Despite this positive news, the stock traded 3.8% lower in after-hours trading, indicating investor caution regarding the offering. Additionally, Galecto appointed former Blueprint Medicines executives as COO and CMO, which may enhance its strategic direction.

This public offering could provide Galecto with the necessary capital to advance its projects and strengthen its position in the biopharmaceutical sector, although investor sentiment appears mixed.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for NVDA?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy NVDA?

Get Started Free